Drugs / MB-CART2219.1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07108868 | Jun 2025 → Mar 2027 expected | childhood acute lymphoblastic leukemia, chronic lymphocytic leukemia/small lymphocytic lymphoma | University Hospital Tuebingen | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MB-CART2219.1 | “A Phase I Dose Finding Study of MB-CART2219.1” NCT07108868 ↗ |